AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
+4.72%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(+6.2%)
Cap. Flow
+$5.37M
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$92.7M |
Top Sells
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$80.7M |
| 2 |
Denali Therapeutics
DNLI
|
$6.71M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.39B
| $92.7M | 56.72% |
+3,233,490
| New | +$92.7M |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $28M | 17.13% |
2,008,809
| – | – |
|
3
Erasca
ERAS
$454M
| $23.5M | 14.4% |
11,055,554
| – | – |
|
|
4
Denali Therapeutics
DNLI
$2.26B
| $8.18M | 5% |
381,249
-312,500
| -45% | -$6.71M |
|
5
Gossamer Bio
GOSS
$589M
| $7.35M | 4.5% |
8,055,916
| – | – |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $1.94M | 1.19% |
1,004,817
| – | – |
|
|
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.75M | 1.07% |
3,798,926
| – | – |
|
|
EQRX
8
DELISTED
EQRx, Inc. Common Stock
EQRX
| – | – |
-36,335,375
| Closed | -$80.7M |
|